Loading...

Intermountain, Asia Genomics partner for personalized medicine

 13-Sep-16, Healthcare IT News 

Intermountain Precision Genomics and Asia Genomics are joining forces to deliver personalized medicine. First up is a test in Southeast Asia.

Intermountain Asia Genomics partner for personalized medicine (c) Healthcare IT News

Image: Healthcare IT News

Under the collaboration deal, the first for Intermountain Precision Genomics outside of the US, Asia Genomics is contracting with Intermountain Precision Genomics to offer ICG100 testing.

The ICG100 test is next generation sequencing that identifies mutations within a person’s cancer to identify specific DNA targets for personalized drug treatments. The IGC100 test is approved for late stage cancer patients who have failed a traditional treatment method, offering new hope when traditional treatments don’t work.

Asia Genomics has been offering various types of genomic tests in the healthcare environment since 2014. The tests primarily center on reproductive health and cancer care.

 Read the full article  

 Insights 

Share